Artal Group’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-381,554
| Closed | -$14.9M | – | 96 |
|
|
2024
Q2 | $14.9M | Buy |
381,554
+128,167
| +51% | +$5M | 0.38% | 28 |
|
|
2024
Q1 | $10.9M | Buy |
+253,387
| New | +$10.9M | 0.28% | 40 |
|
|
2018
Q4 | – | Sell |
-250,000
| Closed | -$3.3M | – | 103 |
|
|
2018
Q3 | $3.3M | Buy |
250,000
+100,000
| +67% | +$1.32M | 0.09% | 65 |
|
|
2018
Q2 | $1.38M | Hold |
150,000
| – | – | 0.03% | 74 |
|
|
2018
Q1 | $735K | Hold |
150,000
| – | – | 0.01% | 81 |
|
|
2017
Q4 | $424K | Hold |
150,000
| – | – | 0.01% | 83 |
|
|
2017
Q3 | $443K | Hold |
150,000
| – | – | 0.01% | 80 |
|
|
2017
Q2 | $473K | Hold |
150,000
| – | – | 0.01% | 79 |
|
|
2017
Q1 | $600K | Buy |
+150,000
| New | +$600K | 0.01% | 72 |
|